Genital Cancer

Genital Cancer - most related articles:

- Gardasil HPV vaccine prevented genital lesions in men - 5.5
- Herpes medication does not reduce HIV transmission risk - 3.9
- Gardasil is eligible for UN immunization programs - 3.9
- Non earlobe body piercing raises complications - 3.9
- Gardasil efficacious against HPV 16 infection - 3.8
- Gardasil vaccine to prevent cervical cancer in India - 3.4
- Gardasil approved to prevent anal cancer - 3.3
- Cervical cancer screening to 50000 women in India - 3.1
- Benefit to women not enough to sway men to get HPV vaccine - 3
- Environmental chemicals in breast milk may cause testicular cancer later - 2.5

Genital Cancer articles

HPV vaccine reduces subsequent cervical disease in women
HPV vaccination does not reduce progression to cervical disease in women, but vaccinated women had less frequent subsequent cervical disease. Women who are diagnosed with pre-cancerous cervical conditions after receiving the HPV vaccine can still benefit from a considerably reduced risk of reoccurring disease.

Benefit to women not enough to sway men to get HPV vaccine
Informing men that a new vaccine to prevent human papillomavirus (HPV) would also help protect their female partners against developing cervical cancer from the sexually transmitted infection did not increase their interest in getting the vaccine, according to a new Florida State University study.

Gardasil efficacious against HPV 16 infection
In a study of an extended follow up of 290 women naïve to HPV type 16, the HPV 16 component of GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] was efficacious against HPV 16 infection for an average of 8.5 years after administration.

Gardasil HPV vaccine prevented genital lesions in men
GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], the cervical cancer vaccine from Merck & Co., Inc., prevented 90 percent of external genital lesions caused by human papillomavirus (HPV) types 6, 11, 16 and 18 in a pivotal Phase III study in men aged 16 to 26.

Gardasil vaccine to prevent cervical cancer in India
MSD Pharmaceuticals India announced the launch of GARDASIL Vaccine, India's first vaccine to help prevent Cervical Cancer caused by the HPV.

5 Genital Cancer articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
4.82